Relieves itchy eyes due to ragweed, pollen, grass, animal hair and dander. Sold as Zaditor, Alaway, Children'S Alaway, Acuvue Theravision With Ketotifen. Every FDA application for this active ingredient: 3 branded and 5 generic.
As of Nov 15, 2026, FDA lists 8 applications for Ketotifen Fumarate (sold as Zaditor, Alaway, Children'S Alaway and others), first approved Jul 2, 1999, with 2 new uses approved and 0 published complete response letters.
| Mast Cell Treatment in Post-tick Bite Illness (PTBI)Tick Bites, Mast Cell Activation Disorders · University of North Carolina, Chapel Hill | Phase 2 | Not yet recruiting | Apr 13, 2026 |
| Topical Ketotifen 0.25% for Secondary VestibulodyniaProvoked Vestibulodynia, Secondary Provoked Vestibulodynia · Center for Vulvovaginal Disorders | Phase 2 | Recruiting | Dec 2, 2025 |
| Topical Metformin Versus Topical Ketotifen in Melasma TreatmentMelasma · Assiut University | Phase 2 | Not yet recruiting | Apr 24, 2025 |
| The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral NeuropathyNeuropathy;Peripheral · Tanta University | Phase 3 | Recruiting | Nov 21, 2022 |
| Ketotifen for Children With Functional Dyspepsia in Association With Duodenal EosinophiliaFunctional Dyspepsia · Craig A. Friesen, MD | Phase 3 | Recruiting | Jun 29, 2015 |
| A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal EctasiaKeratoconus, Ectasia · Massachusetts General Hospital | — | Recruiting | Apr 21, 2014 |
| Jul 2, 1999 | ZaditorNDA 21066 · New molecular entity | Alcon Pharma | 9 | Discontinued |
| May 9, 2006 | Ketotifen FumarateANDA 77354 | Apotex Inc | 1 | Discontinued |
| Dec 1, 2006 | Alaway, Children'S AlawayNDA 21996 · New formulation or manufacturer | Bausch And Lomb | 4 | Marketed |
| Jul 26, 2007 | Ketotifen FumarateANDA 77958 | Sentiss | 1 | Marketed |
| Sep 2, 2008 | ZaditorANDA 77200 | Alcon Pharms Ltd | 1 | Marketed |
| Jun 1, 2020 | Ketotifen FumarateANDA 204059 | Unichem | 0 | Marketed |
| Sep 24, 2020 | AlawayANDA 208158 | Bausch And Lomb Inc | 0 | Discontinued |
| Feb 25, 2022 | Acuvue Theravision With KetotifenNDA 22388 · TYPE 3/4 | Johnson Johnson Visn | 1 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA